ANXA1 and cancer: However, the impact of RRM2 on the sensitivity of PCA to docetaxel treatment is not yet clear.Annexin A1 (ANXA1) is a calcium dependent phospholipid binding protein closely related to various cellular activities, such as inflammation and apoptosis, as well as cancer cell proliferation [13, 14].